Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Centre Hospitalier Regional et Universitaire de Lille
Lila, FranciaCentre Hospitalier Regional et Universitaire de Lille-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422